333 related articles for article (PubMed ID: 22674530)
1. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis.
Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Acta Pharmacol Sin; 2007 Nov; 28(11):1835-41. PubMed ID: 17959036
[TBL] [Abstract][Full Text] [Related]
3. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
Yuan XW; Zhu XF; Liang SG; Fan Q; Chen ZX; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Life Sci; 2008 Feb; 82(7-8):393-401. PubMed ID: 18191951
[TBL] [Abstract][Full Text] [Related]
4. Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells.
Sapio L; Sorvillo L; Illiano M; Chiosi E; Spina A; Naviglio S
Molecules; 2015 Sep; 20(9):15910-28. PubMed ID: 26340617
[TBL] [Abstract][Full Text] [Related]
5. S-Adenosylmethionine Affects ERK1/2 and Stat3 Pathways and Induces Apotosis in Osteosarcoma Cells.
Ilisso CP; Sapio L; Delle Cave D; Illiano M; Spina A; Cacciapuoti G; Naviglio S; Porcelli M
J Cell Physiol; 2016 Feb; 231(2):428-35. PubMed ID: 26174106
[TBL] [Abstract][Full Text] [Related]
6. Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated Bcl-2 silencing.
Zhao Y; Zhang CL; Zeng BF; Wu XS; Gao TT; Oda Y
Biochem Biophys Res Commun; 2009 Dec; 390(3):642-7. PubMed ID: 19818735
[TBL] [Abstract][Full Text] [Related]
7. Depletion of Neuroguidin/CANu1 sensitizes human osteosarcoma U2OS cells to doxorubicin.
Park JH; Sihn CR; Lee YS; Lee SJ; Kim SH
BMB Rep; 2011 Jan; 44(1):46-51. PubMed ID: 21266106
[TBL] [Abstract][Full Text] [Related]
8. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
9. [Interferon α sensitizes human osteosarcoma cells to doxorubicin-induced apoptosis through p53-dependent pathway].
Yuan XW; Huang XF; Chen ZX; Liang SG; Liao WM
Zhonghua Yi Xue Za Zhi; 2016 Oct; 96(37):3008-3013. PubMed ID: 27760664
[No Abstract] [Full Text] [Related]
10. Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells.
Spina A; Sorvillo L; Chiosi E; Esposito A; Di Maiolo F; Sapio L; Caraglia M; Naviglio S
Oncol Rep; 2013 May; 29(5):1689-96. PubMed ID: 23446517
[TBL] [Abstract][Full Text] [Related]
11. Inorganic phosphate inhibits growth of human osteosarcoma U2OS cells via adenylate cyclase/cAMP pathway.
Naviglio S; Spina A; Chiosi E; Fusco A; Illiano F; Pagano M; Romano M; Senatore G; Sorrentino A; Sorvillo L; Illiano G
J Cell Biochem; 2006 Aug; 98(6):1584-96. PubMed ID: 16552724
[TBL] [Abstract][Full Text] [Related]
12. Inorganic phosphate as a signaling molecule: a potential strategy in osteosarcoma treatment.
Spina A; Sorvillo L; Esposito A; Borgia A; Sapio L; Naviglio S
Curr Pharm Des; 2013; 19(30):5394-403. PubMed ID: 23394088
[TBL] [Abstract][Full Text] [Related]
13. The p33ING1b tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells.
Zhu JJ; Li FB; Zhu XF; Liao WM
Life Sci; 2006 Feb; 78(13):1469-77. PubMed ID: 16325212
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
15. Suppression of Estrogen Receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell.
Wang JY; Chen CM; Chen CF; Wu PK; Chen WM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681897
[TBL] [Abstract][Full Text] [Related]
16. p53 siRNA inhibits apoptosis of U2OS cells treated with azurin.
Yan X; Feng J; Ye Z; Miao X; Li W; Yang D
Mol Med Rep; 2011; 4(6):1089-94. PubMed ID: 21822538
[TBL] [Abstract][Full Text] [Related]
17. [Selective inducement effect of bacterial redox protein azurin on apoptosis of human osteosarcoma cell line U2OS].
Ye ZM; Miao XD; Yang DS; Xu RZ; Huang X; Ge FF
Ai Zheng; 2005 Mar; 24(3):298-304. PubMed ID: 15757530
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
[TBL] [Abstract][Full Text] [Related]
19. Novel molecular mechanisms by inorganic phosphate in osteosarcoma U2OS cells.
Naviglio S; Di Gesto D; Borrelli V; Forni M; Illiano F; D'Auria R; Sorrentino A; Chiosi E; Illiano G; Spina A
Front Biosci (Elite Ed); 2011 Jun; 3(4):1249-58. PubMed ID: 21622131
[TBL] [Abstract][Full Text] [Related]
20. Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2.
Zhang C; Zhao Y; Zeng B
Cancer Biomark; 2012; 12(4):155-67. PubMed ID: 23568006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
